MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Drug-induced parkinsonism with resting tremor

    M. Nomoto, A. Watanabe (Imabari Ehime, Japan)

    Objective: Resting tremor might be developed by long-term treatment of dopamine receptor antagonists in cases of drug-induced parkinsonism Background: Resting tremor is one of the…
  • 2025 International Congress

    Laryngeal Dystonia, Dopa-Responsive Parkinsonism and Primary Progressive Aphasia with Alzheimer Disease Pathology

    A. Eid, R. Perrin, J. Perlmutter, S. Norris (Saint Louis, USA)

    Objective: To report a case of laryngeal dystonia (LD), parkinsonism and primary progressive aphasia (PPA) with Alzheimer disease (AD) pathology Background: The presence of 3-4 neurological…
  • 2025 International Congress

    Stepping backwards to move forward A case study on novel PT interventions for DLB

    K. Vasher, A. Boddy (Loma Linda, USA)

    Objective: Explore the effectiveness of backwards walking and backwards stepping interventions to improve gait stability and balance in persons with Dementia with Lewy Bodies (DLB).…
  • 2025 International Congress

    An Interesting Case of Oculo-Palatal-Pharyngeal Tremor

    R. Robinson, A. Oswal, MT. Hu (Oxford, United Kingdom)

    Objective: We present a case report of a 59 year old with a diagnosis of clinically possible progressive supranuclear palsy (PSP) and clinical finding of…
  • 2025 International Congress

    Peripheral unspecific inflammatory parameters – not always useful in differential diagnosis of parkinsonian syndromes.

    N. Madetko-Alster, P. Alster (Warsaw, Poland)

    Objective: To determine utility of systemic inflammation response index (SIRI) and systemic immune-inflammation index (SII) in differential diagnosis of Parkinson’s disease (PD), progressive supranuclear palsy-Richardson’s…
  • 2025 International Congress

    Plasma tau-species-containing neuron-derived extracellular vesicles as potential biomarkers for progressive supranuclear palsy

    YC. Zheng, HH. Cai, WY. Kou, ZW. Yu, T. Feng (Beijing, China)

    Objective: This study aimed to develop and validate novel plasma PSP biomarkers based on tau-species-containing neuron-derived extracellular vesicles (NDEVs) in two independent cohorts (discovery and…
  • 2025 International Congress

    Differences Between Clinical and Imaging Phenotypes in Phase 2 Study of ATH434 in Multiple System Atrophy

    P. Trujillo, K. Hett, M. Bradbury, C. Wong, D. Stamler, D. Claassen (Nashville, USA)

    Objective: To assess differences between clinical and imaging phenotypes in Multiple System Atrophy (MSA) and evaluate the reliability of imaging biomarkers for subtype classification. Background:…
  • 2025 International Congress

    Case report and Literature Review on Atypical Parkinson’s Disease

    MJ. Dashdorj (Ulaanbaatar, Mongolia)

    Objective: Atypical parkinsonism is classified as a subgroup of Progressive neurodegenerative diseases, characterized by symptoms of Parkinson's disease. Background: Progressive supra nuclear palsy of the…
  • 2025 International Congress

    Identification of Genetic Variants in Progressive Supranuclear Palsy in China

    Y. Kang, W. Luo (Hangzhou, China)

    Objective: To delineate the genetic landscape of progressive supranuclear palsy (PSP) in Chinese patients.Progressive supranuclear palsy is a neurodegenerative disorder primarily considered sporadic, with MAPT…
  • 2025 International Congress

    The effectiveness and safety of autologous adipose derived stromal vascular components (SVF) in the treatment of multiple system atrophy

    ZL. Cai, RX. Li, JW. Li (Suzhou, China)

    Objective: This study aimed to explore the efficacy and safety of autologous adipose - derived stromal vascular fraction (SVF) in treating MSA. Background: Multisystem atrophy…
  • « Previous Page
  • 1
  • …
  • 90
  • 91
  • 92
  • 93
  • 94
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • VIT-D and Tics Movement Disorder
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley